The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD)
Fig 1
Flow of the study references from identification during the search, through screening and eligibility and up until inclusion. The search strategy and eligibility criteria are detailed in the methods section. Briefly, all clinical studies of antischistosomal drugs, completed in 2000 or later and performed in an endemic setting, were included if at least some of the recruited participants were diagnosed for infection with Schistosoma spp. before and within 60 days after treatment.